CN1819837A - Tamandarin类似物及其片段以及制备和使用方法 - Google Patents

Tamandarin类似物及其片段以及制备和使用方法 Download PDF

Info

Publication number
CN1819837A
CN1819837A CNA2004800133883A CN200480013388A CN1819837A CN 1819837 A CN1819837 A CN 1819837A CN A2004800133883 A CNA2004800133883 A CN A2004800133883A CN 200480013388 A CN200480013388 A CN 200480013388A CN 1819837 A CN1819837 A CN 1819837A
Authority
CN
China
Prior art keywords
compound
mmol
methyl
side chain
proline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004800133883A
Other languages
English (en)
Chinese (zh)
Inventor
玛德琳·M.·茹利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN1819837A publication Critical patent/CN1819837A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA2004800133883A 2003-03-21 2004-03-19 Tamandarin类似物及其片段以及制备和使用方法 Pending CN1819837A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45696703P 2003-03-21 2003-03-21
US60/456,967 2003-03-21

Publications (1)

Publication Number Publication Date
CN1819837A true CN1819837A (zh) 2006-08-16

Family

ID=33098178

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2004800133883A Pending CN1819837A (zh) 2003-03-21 2004-03-19 Tamandarin类似物及其片段以及制备和使用方法

Country Status (8)

Country Link
US (1) US8030279B2 (https=)
EP (1) EP1613338A4 (https=)
JP (1) JP2006523214A (https=)
CN (1) CN1819837A (https=)
AU (1) AU2004224418A1 (https=)
CA (1) CA2519234A1 (https=)
MX (1) MXPA05010064A (https=)
WO (1) WO2004084812A2 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1423564A (zh) * 1999-11-15 2003-06-11 法马马有限公司 癌症的aplidine治疗
US6509315B1 (en) 2000-04-07 2003-01-21 The Trustees Of The University Of Pennsylvania Didemnin analogs and fragments and methods of making and using them
ES2272462T3 (es) * 2000-04-07 2007-05-01 The Trustees Of The University Of Pennsylvania Analogos de tamadarina y didemnina y procedimiento de fabricacion y uso.
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
ATE512211T1 (de) 2005-05-31 2011-06-15 Iams Company Feline probiotische lactobacilli
EP1942193A4 (en) 2005-08-25 2010-10-27 Ube Industries METHOD FOR THE PRODUCTION OF OPTICALLY ACTIVE (S OR R) -AMINOIC ACID OR AN OPTICALLY ACTIVE (S OR R) -α-AMINO-ACID ESTER
CN101389347B (zh) 2006-02-28 2013-03-27 法马马有限公司 提高的抗肿瘤治疗
EP2124966B1 (en) 2007-02-01 2015-09-09 IAMS Europe B.V. Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
JP5396016B2 (ja) * 2007-03-26 2014-01-22 学校法人青山学院 化合物又はその薬理上許容される塩若しくはエステル誘導体及び制癌剤
AU2008313627A1 (en) * 2007-10-19 2009-04-23 Pharma Mar, S.A. Improved antitumoral treatments
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
WO2011020913A2 (en) 2009-08-21 2011-02-24 Pharma Mar, S.A. Cyclodepsipeptide antiviral compounds
CN104003908B (zh) * 2014-01-17 2016-08-17 宁波北仑大港科技创新服务中心 一种保护羟基的丝氨酸的制备方法
HRP20231233T1 (hr) 2017-04-27 2024-01-19 Pharma Mar, S.A. Antitumorski spojevi
CA3169544A1 (en) 2020-03-02 2021-09-10 Pablo Aviles Marin Compounds for use in inflammatory conditions
US20230158104A1 (en) 2020-03-02 2023-05-25 Pharma Mar, S.A. Compounds for use in autoimmune conditions
WO2021175826A1 (en) 2020-03-02 2021-09-10 Pharma Mar, S.A. Compounds for use in the treatment of coronavirus infection
US12168640B2 (en) 2021-11-16 2024-12-17 ProDeg, LLC USP9X inhibitors
EP4433462A4 (en) * 2021-11-16 2025-07-16 Prodeg Llc USP9X INHIBITORS
WO2024165764A1 (en) 2023-02-10 2024-08-15 Pharma Mar, S.A. Plitidepsin for use in the treatment of non-integrated dna viral infections

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4782135A (en) 1980-09-12 1988-11-01 Board Of Trustees, University Of Illinois Composition of matter and process
US4493796A (en) 1980-09-12 1985-01-15 Board Of Trustees, Univ. Of Ill. Didemnins A, B, C, and derivatives thereof, as antiviral agents
US5137870A (en) 1980-09-12 1992-08-11 The Board Of Trustees Of The University Of Illinois Didemnins and nordidemnins
DE4120327A1 (de) 1991-06-20 1992-12-24 Basf Ag Neue peptide, ihre herstellung und verwendung
ES2102322B1 (es) 1995-07-13 1998-03-01 Pharma Mar Sa Procedimiento de preparacion de didemnina a.
DE69735583T2 (de) 1996-10-24 2007-04-05 The Board Of Trustees Of The University Of Illinois, Urbana Semisynthetisches verfahren zur herstellung von didemninanalogen
PT956033E (pt) 1996-10-24 2003-10-31 Univ Illinois SíNTESE TOTAL DE ANALOGOS AMINO HIP DE DIDEMNINA A
US6509315B1 (en) * 2000-04-07 2003-01-21 The Trustees Of The University Of Pennsylvania Didemnin analogs and fragments and methods of making and using them
ES2272462T3 (es) * 2000-04-07 2007-05-01 The Trustees Of The University Of Pennsylvania Analogos de tamadarina y didemnina y procedimiento de fabricacion y uso.
UA76718C2 (uk) 2000-06-30 2006-09-15 Фарма Мар, С.А. Протипухлинні похідні аплідину
SE523235C2 (sv) * 2003-02-21 2004-04-06 Water Treat Construction I Mot Metod och anordning för att avskilja miljöfarliga ämnen ur en förorenad massa

Also Published As

Publication number Publication date
MXPA05010064A (es) 2006-05-17
US20070149446A1 (en) 2007-06-28
AU2004224418A1 (en) 2004-10-07
EP1613338A2 (en) 2006-01-11
WO2004084812A3 (en) 2005-10-06
CA2519234A1 (en) 2004-10-07
EP1613338A4 (en) 2009-06-24
JP2006523214A (ja) 2006-10-12
US8030279B2 (en) 2011-10-04
WO2004084812A2 (en) 2004-10-07

Similar Documents

Publication Publication Date Title
CN1819837A (zh) Tamandarin类似物及其片段以及制备和使用方法
CN1094943C (zh) 诱导产生细胞素的尿烷类和尿素化合物
CN1051083C (zh) 有免疫调节活性的新的取代嘌呤基衍生物
CN1168702C (zh) 酰基-二肽类化合物,其制备方法以及含有前述化合物的药物组合物
CN1117760C (zh) 溶酶体酶可裂解的抗肿瘤药物结合物
CN1553897A (zh) 多拉司他汀10衍生物
US7678765B2 (en) Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
CN1225471C (zh) 具有生长激素释放特性的化合物
CN1232507C (zh) 生长激素促分泌剂
US7651997B2 (en) Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them
CN1856502A (zh) 抗c型肝炎病毒活性的巨环肽
CN1323314A (zh) 卡斯帕酶抑制剂
CN1512999A (zh) 2{[n-(2-氨基-3-(杂芳基或芳基)丙酰基)-氨基酰基]-氨基}-烷基硼酸衍生物
CN1272114A (zh) 苯乙胺衍生物
CN1040211C (zh) 基质金属蛋白酶抑制剂
CN1179972C (zh) 促生长激素分泌剂
CN1127488C (zh) 具有生长激素释放特性的化合物
CN101056887A (zh) 用作溶杆菌素衍生物的酰化九酯肽类
CN1112555A (zh) 环氧琥珀酸衍生物
CN1347419A (zh) 吡咯烷羰基氨基环状二硫化物
CN1373770A (zh) 假单胞菌素前药
CN1227261C (zh) 具有nk－2拮抗作用的含有四个双官能基团的单环类化合物，其制法，药物组合物及用途
CN1202174A (zh) 肽衍生物
CN1311794A (zh) 气丝菌素类似物、它们的制备和用途
CN1942466A (zh) 天冬氨酸特异性半胱氨酸蛋白酶抑制剂及其用途

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20060816